Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Daali

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Clinical Pharmacology and Therapeutics|January 13, 2012
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spotY Daali, C Samer, J Déglon, et al.
Clinical Pharmacology and Therapeutics|April 12, 2014
Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spotsM Bosilkovska, C F Samer, J Déglon, et al.
The Pharmacogenomics Journal|July 2, 2008
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionM C Rebsamen, J Desmeules, Y Daali, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 2, 2022
Drug metabolic enzyme genotype-phenotype discrepancy: High phenoconversion rate in patients treated with antidepressantsY Gloor, C Lloret-Linares, M Bosilkovska, et al.
Journal of Viral Hepatitis|July 6, 2012
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionF Girardin, Y Daali, M Gex-Fabry, et al.
British Journal of Pharmacology|July 2, 2010
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneC F Samer, Y Daali, M Wagner, et al.
The Pharmacogenomics Journal|October 30, 2013
The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantationC R S Uppugunduri, M A Rezgui, P H Diaz, et al.
British Journal of Pharmacology|July 2, 2010
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyC F Samer, Y Daali, M Wagner, et al.
Clinical Pharmacology and Therapeutics|February 10, 2017
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the futureA S Darwich, K Ogungbenro, A A Vinks, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical Pharmacology and Therapeutics|January 13, 2012
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spotY Daali, C Samer, J Déglon, et al.
Clinical Pharmacology and Therapeutics|April 12, 2014
Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spotsM Bosilkovska, C F Samer, J Déglon, et al.
The Pharmacogenomics Journal|July 2, 2008
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionM C Rebsamen, J Desmeules, Y Daali, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 2, 2022
Drug metabolic enzyme genotype-phenotype discrepancy: High phenoconversion rate in patients treated with antidepressantsY Gloor, C Lloret-Linares, M Bosilkovska, et al.
Journal of Viral Hepatitis|July 6, 2012
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionF Girardin, Y Daali, M Gex-Fabry, et al.
British Journal of Pharmacology|July 2, 2010
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneC F Samer, Y Daali, M Wagner, et al.
The Pharmacogenomics Journal|October 30, 2013
The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantationC R S Uppugunduri, M A Rezgui, P H Diaz, et al.
British Journal of Pharmacology|July 2, 2010
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyC F Samer, Y Daali, M Wagner, et al.
Clinical Pharmacology and Therapeutics|February 10, 2017
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the futureA S Darwich, K Ogungbenro, A A Vinks, et al.
Pageof 3